Literature DB >> 33953458

Vulvar lichen sclerosus in women of reproductive age.

Elysha Kolitz1, Laura Gammon2, Melissa Mauskar1,3.   

Abstract

Vulvar lichen sclerosus (vLS) is an inflammatory skin condition that predominantly affects the vulvar and perianal regions. Approximately 50% of cases present prior to menopause; however, there is a paucity of data on vLS in women of reproductive age as well as during their pregnancies. A retrospective review was performed at two tertiary referral centers to better describe cases of vLS in women of reproductive age. Thirty-three patients with a mean age of 40 years met inclusion criteria. In this group, vulvar pruritus was the most common presenting symptom (52%); 61% had biopsy-proven vLS, 42% had at least one autoimmune condition, 21% had comorbid depression or anxiety, 33% were given an incorrect diagnosis prior to vLS, and 42% had documented nonadherence to topical steroids. Among the eight patients who became pregnant, four had cesarean deliveries and 63% were symptomatic during pregnancy. When treating a woman who presents with vulvar pruritus or skin changes, vLS should be considered.
Copyright © 2021 Baylor University Medical Center.

Entities:  

Keywords:  Genital; lichen sclerosus; pregnancy; reproductive age; vulvar lichen sclerosuslichen sclerosus

Year:  2021        PMID: 33953458      PMCID: PMC8059896          DOI: 10.1080/08998280.2021.1885093

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  14 in total

1.  The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream.

Authors:  K L Dalziel; P R Millard; F Wojnarowska
Journal:  Br J Dermatol       Date:  1991-05       Impact factor: 9.302

Review 2.  Genital Lichen Sclerosus and its Mimics.

Authors:  Anuja Vyas
Journal:  Obstet Gynecol Clin North Am       Date:  2017-09       Impact factor: 2.844

3.  Clinical outcomes and adherence to topical corticosteroid therapy in women with vulvar lichen sclerosus: A retrospective cohort study.

Authors:  Jaden R Kohn; Trissa M Connors; Warren Chan; Cynthia S Liang; Harry Dao; Anuja Vyas
Journal:  J Am Acad Dermatol       Date:  2020-05-06       Impact factor: 11.527

4.  Lichen sclerosus in pregnancy: A review of 33 cases.

Authors:  Yvonne Nguyen; Jennifer Bradford; Gayle Fischer
Journal:  Aust N Z J Obstet Gynaecol       Date:  2018-06-19       Impact factor: 2.100

5.  Vulvar lichen sclerosus in women is associated with lower urinary tract symptoms.

Authors:  Corina Christmann-Schmid; Melanie Hediger; Sabine Gröger; Jörg Krebs; Andreas R Günthert
Journal:  Int Urogynecol J       Date:  2017-06-07       Impact factor: 2.894

6.  Long-term Management of Adult Vulvar Lichen Sclerosus: A Prospective Cohort Study of 507 Women.

Authors:  Andrew Lee; Jennifer Bradford; Gayle Fischer
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

7.  The impact of vulvar lichen sclerosus on sexual dysfunction.

Authors:  Hope K Haefner; Nely Z Aldrich; Vanessa K Dalton; Hélène M Gagné; Stephanie B Marcus; Divya A Patel; Mitchell B Berger
Journal:  J Womens Health (Larchmt)       Date:  2014-08-27       Impact factor: 2.681

8.  Effects of vulvodynia on quality of life.

Authors:  Maya Ponte; Erika Klemperer; Anju Sahay; Mary-Margaret Chren
Journal:  J Am Acad Dermatol       Date:  2008-11-20       Impact factor: 11.527

Review 9.  Lichen Sclerosus: An autoimmunopathogenic and genomic enigma with emerging genetic and immune targets.

Authors:  Davis A Tran; Xiaohui Tan; Charles J Macri; Andrew T Goldstein; Sidney W Fu
Journal:  Int J Biol Sci       Date:  2019-06-02       Impact factor: 6.580

Review 10.  Etiology, Clinical Features, and Diagnosis of Vulvar Lichen Sclerosus: A Scoping Review.

Authors:  Nilanchali Singh; Prafull Ghatage
Journal:  Obstet Gynecol Int       Date:  2020-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.